1. Acknowledgement to Referees

   Acknowledgement to Referees 20 November 2021 Pages: 1233 - 1238

2. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders

   • Ruyan Wu
   • Jun-Xu Li

   Leading Article 12 November 2021 Pages: 1239 - 1248

   

3. Vitamin D Supplementation and Cognition in Adults: A Systematic Review of Randomized Controlled Trials

   • Olivier Beauchet
   • Liam A. Cooper-Brown
   • Gilles Allali

   Systematic Review 22 November 2021 Pages: 1249 - 1264

   

4. Antipsychotic-Induced Constipation: A Review of the Pathogenesis, Clinical Diagnosis, and Treatment

   • Yue Xu
   • Nousayhah Amdanee
   • Xiangrong Zhang

   Review Article 24 August 2021 Pages: 1265 - 1274

5. The Impact of Lithium on Brain Function in Bipolar Disorder: An Updated Review of Functional Magnetic Resonance Imaging Studies

   • Emilio Bergamelli
   • Lorenzo Del Fabro
   • Paolo Brambilla

   Review Article Open access 12 November 2021 Pages: 1275 - 1287

   

6. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)

   • Simona Lattanzi
   • Laura Canafoglia
   • BRIVAFIRST Group Membership

   Original Research Article Open access 02 September 2021 Pages: 1289 - 1301

   

7. Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials

   • Nathaniel F. Watson
   • Craig W. Davis
   • Jean-Charles Schwartz

   Original Research Article Open access 25 November 2021 Pages: 1303 - 1315

   

8. Nusinersen: A Review in 5q Spinal Muscular Atrophy

   • Sheridan M. Hoy

   Adis Drug Evaluation Open access 30 November 2021 Pages: 1317 - 1328

9. Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)

   • Simona Lattanzi
   • Laura Canafoglia
   • BRIVAFIRST Group Membership

   Correction Open access 17 November 2021 Pages: 1329 - 1331

10. Comment on “Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis”

    • Johanne Pereira Ribeiro
    • Mie Sedoc Jørgensen
    • Ole Jakob Storebø

    Letter to the Editor 07 November 2021 Pages: 1333 - 1334

11. Authors’ Reply to Pereira Ribeiro et al.: Comment on “Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta‑Analysis”

    • Gerald Gartlehner
    • Karen Crotty
    • Meera Viswanathan

    Letter to the Editor 07 November 2021 Pages: 1335 - 1336